HIMSSCast: The future of telehealth reimbursement

Limits and uncertainty all around telehealth reimbursement have constantly been an impediment to adoption. Throughout the COVID-19 unexpected emergency, that load was eased to some degree, but now the new standard is starting up to acquire form. What boundaries nonetheless remain to telehealth reimbursement, and how may well they be overcome? To remedy that dilemma, host Jonah Comstock and Health care Finance Information Running Editor Susan Morse welcome McKinsey & Corporation partners Oleg Bestsennyy and Gunjan Khanna.

This episode is introduced to you by BlueJeans.

Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Participate in!

Speaking points:

• COVID-19 reimbursement improvements and which of them will stick all around
• Adoption lessons learned and how they’ll influence reimbursement plan
• Holistic tele-treatment and treatment past the online video stop by
• Influence of new entrants and innovation on the room
• Is rate-for-provider reimbursement an innovation blocker?
• Reimbursement for diverse telehealth modalities
• Time to guide instead than adhere to for personal payers?
• The nonetheless-unresolved dilemma of induced utilization
• The increase of worth-dependent treatment and hybrid treatment types
• Telehealth reimbursement and wellness equity
• How are individuals feeling about telehealth now?
• Last views: the long run of telehealth reimbursement

More about this episode:

Report displays ‘vast improvement’ in state telehealth reimbursement guidelines

COVID-19 could forever change the telehealth landscape, from reimbursement to utilization

Telehealth reimbursement parity spurs insurance company concerns of overutilization

CMS will reimburse for eleven new telehealth solutions in the course of the general public wellness unexpected emergency

Congressional motion is essential for telehealth not to return to a rural reward, Seema Verma says

Telehealth: A quarter-trillion-dollar article-COVID-19 actuality? (McKinsey)

COVID-19 Client Health care Insights: What 2021 could hold (McKinsey)

How COVID-19 has changed the way US people consider about healthcare (McKinsey)